Signs of Digoxin Toxicity
Digoxin toxicity presents with a characteristic triad of cardiac arrhythmias, gastrointestinal symptoms, and neurological manifestations, with diagnosis confirmed by serum digoxin levels typically >2 ng/mL, though toxicity can occur even within therapeutic range. 1
Cardiac Manifestations
The cardiac signs are the most critical and potentially life-threatening:
- Enhanced automaticity with conduction block is the hallmark pattern—look for ectopic atrial, junctional, or ventricular beats combined with atrioventricular block 1
- Bidirectional or fascicular ventricular tachycardia is highly specific for digoxin toxicity and should immediately raise suspicion 1
- Conduction disturbances include first-degree, second-degree (Wenckebach), or third-degree heart block, which may progress to asystole 2
- Atrial tachycardia with block, accelerated junctional rhythm, and ventricular ectopy (especially bigeminy or trigeminy) are common 2
- Severe overdose causes hyperkalemia and cardiac standstill 1
- PR prolongation and ST segment depression occur but should not by themselves be considered toxicity 2
Gastrointestinal Manifestations
These are often the earliest symptoms in adults:
- Anorexia, nausea, and vomiting are the most common GI symptoms 1, 2
- Diarrhea and abdominal pain occur frequently 2
- Rarely, intestinal ischemia and hemorrhagic necrosis of the intestines can develop 2
Neurological Manifestations
CNS symptoms are less common but diagnostically important:
- Visual disturbances are classic—blurred vision, yellow-green color vision (xanthopsia), photopsia, and "snowy" vision 1, 2
- Confusion and altered mental status may be the sole presenting feature, especially in elderly patients 1, 3
- Headache, weakness, dizziness, and apathy are frequent 2
- Psychiatric symptoms including anxiety, depression, delirium, and hallucinations can occur 2
Diagnostic Considerations
The diagnosis requires the combination of characteristic arrhythmias, ancillary symptoms, and elevated serum concentrations 1:
- Overt toxicity is commonly associated with serum digoxin levels >2 ng/mL 4, 1
- Toxicity can occur even when serum concentration is within therapeutic range (0.5-1.2 ng/mL), particularly in vulnerable patients 1, 5
- The therapeutic window is narrow, with toxic effects typically occurring at concentrations >2.8 ng/mL 6
Critical Risk Factors
These conditions significantly increase susceptibility to toxicity even at lower serum levels:
- Hypokalemia and hypomagnesemia are the most important electrolyte risk factors 1
- Renal dysfunction and advanced age (>70 years) dramatically increase risk 1
- Hypothyroidism potentiates toxicity 1
- Drug interactions with amiodarone, verapamil, clarithromycin, erythromycin, itraconazole, cyclosporine, and propafenone increase digoxin levels 4, 1
Special Considerations in Pediatric Patients
The presentation differs significantly in children:
- Cardiac arrhythmias, including sinus bradycardia, are the earliest and most frequent manifestation in infants and children, not GI symptoms 2
- Conduction disturbances or supraventricular tachyarrhythmias (atrial tachycardia with or without block, junctional tachycardia) are most common 2
- Any arrhythmia in a child taking digoxin should be assumed to be digoxin-induced until proven otherwise 2
Common Pitfalls
- Do not dismiss symptoms in elderly patients with "therapeutic" digoxin levels—toxicity frequently occurs within the therapeutic range in this population 1, 3
- Altered mental status may be the sole manifestation of toxicity, particularly in elderly patients with chronic lung disease 3
- Many extracardiac symptoms (nausea, tiredness, dizziness) are nonspecific and also occur in patients with renal impairment at low digoxin levels, potentially leading to misdiagnosis 7
- In patients with impaired kidney function, extracardiac symptoms have limited diagnostic value for distinguishing toxicity from underlying illness 7